Patent details
EP2367553 Title: COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
Basic Information
- Publication number:
- EP2367553
- PCT Application Number:
- US2009066894
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097716294
- PCT Publication Number:
- WO2010065939
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
- French Title of Invention:
- TRAITEMENT COMBINÉ POUR AMÉLIORER LA CYTOTOXICITÉ INDUITE PAR LES CELLULES NK
- German Title of Invention:
- KOMBINATIONSTHERAPIE ZUR VERSTÄRKUNG NK-ZELLVERMITTELTER CYTOTOXIZITÄT
- SPC Number:
Dates
- Filing date:
- 04/12/2009
- Grant date:
- 03/05/2017
- EP Publication Date:
- 28/09/2011
- PCT Publication Date:
- 10/06/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/05/2017
- EP B1 Publication Date:
- 03/05/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/12/2017
- Expiration date:
- 04/12/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/05/2017
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 Bagsværd, Denmark (DK)
Inventor
- Name:
- FARAG, Sherif, S.
- Address:
- United States (US)
Priority
- Priority Number:
- 120242 P
- Priority Date:
- 05/12/2008
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4439; A61K 39/395; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 201718
- Publication date:
- 03/05/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/04/2018 | Outgoing Correspondence | 1 |